Alzheimer’s disease presents with complex cognitive, behavioral, and functional changes that require nuanced, longitudinal clinical management. This session will examine modern approaches to diagnosis and treatment, with a focus on early identification of Alzheimer’s disease and how timely recognition informs care planning from the outset. Faculty will provide clarity on when and why biomarkers and advanced diagnostic tools are clinically meaningful, and how they can be applied responsibly in practice. The session will also address disease progression and long-term management, integrating pharmacologic and nonpharmacologic strategies to support individualized care across the continuum of Alzheimer’s disease.<br><br>Session developed in partnership with the American Association for Geriatric Psychiatry (AAGP).